Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 and related stress may increase hair loss known as Telogen effluvium.

The man has Temporal Triangular Alopecia, a stable, non-scarring hair loss condition best treated with hair transplantation.

Frontal hair in male pattern baldness shows reduced growth and thickness.

Biotin deficiency is not a major cause of Telogen Effluvium hair loss.

Hypothyroidism patients with hair loss typically have thinning hair, smaller hair follicles, and normal hair shedding.

The document's conclusion cannot be determined from the provided text.

Some medications, including retinoids, antifungals, and psychotropic drugs, can cause reversible hair loss if stopped or doses are reduced.

The document concludes that more research is needed to confirm if blood tests for things like iron and vitamin D are helpful for hair loss from Telogen effluvium.

Women with telogen effluvium have lower levels of iron, folate, and vitamin B12.

A simple wash test can help differentiate between two types of hair loss, and dermatoscopy should be used for further clarification.

Iron deficiency is linked to a common type of hair loss called telogen effluvium.

AGA and TE can be differentiated by specific trichoscopic features, with AGA showing more variation in hair thickness in fronto-temporal areas.

A unified approach is needed to better diagnose and manage Telogen Effluvium, focusing on education, empathy, and safe treatments.

Platelet-Rich Plasma therapy helped significantly in hair recovery for a hair loss condition after infection.

COVID-19 often causes hair loss, especially in women.

Up to 50% of scalp hair can be lost before it appears thin, and treatment is only needed for hair loss caused by diseases or deficiencies.

A woman's COVID-19 related hair loss improved after using a specific hair care routine for 30 days.

Trichoscopy effectively differentiates Androgenetic Alopecia from Telogen Effluvium.

Triangular temporal alopecia can occur in adults and should be correctly identified to prevent misdiagnosis.

The author suggests changing "telogen effluvium" to "telogen defluxion" for hair loss terminology.

Shorter, thinner hairs indicate AGA, while longer, thicker hairs suggest CTE; counting and measuring shed hairs helps diagnose hair loss type.

Hair root dermoscopy is a simple, noninvasive tool to diagnose telogen effluvium.

Androgenetic alopecia is the most common type of non-scarring hair loss, especially in young males, and early diagnosis and treatment are important.

Some blood thinners and blood pressure medicines can cause hair loss, which usually starts 1 to 6 months after beginning the medication.

The man's occipital hair loss was due to temporal triangular alopecia, not alopecia areata.

The hair lotion reduced hair loss and sped up recovery in women with acute telogen effluvium.

People with Chronic Telogen Effluvium mainly have lower iron levels compared to healthy individuals.

The belief about hair shedding phases is likely incorrect and needs reevaluation.

UV rays can cause a type of hair loss known as telogen alopecia.

Women with telogen effluvium should be tested first for vitamin and mineral deficiencies.